FDA’s Device Center Zeroes In On Nitrosamine Contamination Risk
• By Mark McCarty
The US FDA has warned combination product manufacturers to be wary of nitrosamines, antimicrobials used on some catheters that may have carcinogenic properties. (Linaimages/Shutterstock)
